Atlas Trials

Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients

Clinical trial NCT06530290 · UNKNOWN

Trial details

NCT number
NCT06530290
Sponsor
Leila Dargahi. PharmD PhD
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson DiseaseAnxiety
Start date
2022-06-01
Primary completion
2025-12-20
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.